Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

Study Questions:

What was the impact of a quality improvement initiative (Target: Stroke, organized by the American Heart Association/American Stroke Association) aimed at improving door-to-needle (DTN) times for tissue plasminogen activator (tPA) administration in patients with stroke?